Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02161263Completed

Quality of Vision and Quality of Life With LASIK

Role: lead

NCT01135719Not ApplicableCompleted

A Comparison of Fellow Eyes Undergoing LASIK or PRK With a Wavefront-guided Excimer Laser Versus a Wavefront-optimized Excimer Laser

Role: lead

NCT03063164Not ApplicableCompleted

A Comparison of LASIK Outcomes Using Two Femtosecond Lasers

Role: lead

NCT01138189Completed

Wavefront-guided Versus Wavefront-optimized LASIK for Nearsightedness

Role: lead

All 4 trials loaded